Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Recruiting
Observational Study
Pregnancy
Malaria
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 15 – 100
- Sex
- Female
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Amivas Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient received IV Artesunate
* Patient was pregnant while receiving IV Artesunate
* Patient was at least 15 years of age
* Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
Exclusion Criteria
• None
Contacts